您的位置: 首页 > 农业专利 > 详情页

Use of a truncated CCN1 promoter for cancer diagnostics, therapeutics and theranostics
专利权人:
发明人:
Paul B. Fisher,Swadesh K. Das,Rupesh Dash,Devanand Sarkar,Siddik Sarkar,Jolene Windle
申请号:
US14895247
公开号:
US09750823B2
申请日:
2014.06.04
申请国别(地区):
US
年份:
2017
代理人:
摘要:
Recombinant vectors in which expression of one or more elements (e.g. genes required for viral replication, detectable imaging agents, therapeutic agents, etc.) is driven by a truncated CCN 1 cancer selective promoter (tCCN1-Prom) are provided, as are cells and transgenic animals that contain such vectors. The vectors are used in cancer therapy and/or diagnostics, and the transgenic mice are used to monitor cancer progression, e.g. in screening assays.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充